Open AccessImmunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers
Author(s) -
Terry Nolan,
Robert Booy,
Helen Marshall,
Peter Richmond,
Michael D. Nissen,
John B. Ziegler,
Yaela Baine,
Magali Traskine,
Archana Jastorff,
Marie Van der Wielen
Publication year - 2019
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002334
Subject(s) - medicine , reactogenicity , toxoid , immunogenicity , conjugate vaccine , tetanus , vaccination , meningococcal vaccine , neisseria meningitidis , adverse effect , pediatrics , meningococcal disease , meningitis , immunology , immunization , antigen , genetics , biology , bacteria
We assessed immunogenicity, antibody persistence and safety of the meningococcal serogroups A, C, W and Y-tetanus toxoid (TT) conjugate vaccine (MenACWY-TT) in children primed as toddlers with MenC vaccine.